Dutasteride to prevent and treat atherosclerosis
US6630164B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Inventors
Key dates
| Filing date | May 8, 2001 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Jun 24, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/473
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke, and peripheral vascular disease comprising administering to a human or animal an amount of dutasteride sufficient to decrease atherosclerosis and its complications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.